3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Interventions
pembrolizumab
259
Cyclophosphamide
243
Specimen Handling
198
fludarabine
174
Magnetic Resonance Spectroscopy
173
Biopsy
147
Nivolumab
121
Carboplatin
99
Radiotherapy
92
Paclitaxel
88
venetoclax
82
Cisplatin
82
Gemcitabine
79
fludarabine phosphate
78
Injections
69
Ipilimumab
64
Dexamethasone
62
atezolizumab
59
Cetuximab
58
Bevacizumab
58
Radiation
56
Fluorouracil
56
Azacitidine
56
durvalumab
54
Radiosurgery
53
Temozolomide
47
Rituximab
44
Oxaliplatin
44
Docetaxel
44
Irinotecan
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
IPI-549
×
1 year
×
Clear all
NCT07439211
2026-03-03
GAVEL
Dana-Farber Cancer Institute
Phase 1
Not yet recruiting
48 enrolled